3-[(1R)-1-piperazin-1-ylhexyl]benzene-1,2-diol;dihydrochloride
C16H28Cl2N2O2 — CID 171307509
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(1R)-1-piperazin-1-ylhexyl]benzene-1,2-diol;dihydrochloride
3-[(1R)-1-piperazin-1-ylhexyl]benzene-1,2-diol;dihydrochloride (PubChem CID 171307509) has the molecular formula C16H28Cl2N2O2 and a molecular weight of 351.32 g/mol. Its IUPAC name is 3-[(1R)-1-piperazin-1-ylhexyl]benzene-1,2-diol;dihydrochloride.
Molecular Properties
| Compound Name | 3-[(1R)-1-piperazin-1-ylhexyl]benzene-1,2-diol;dihydrochloride |
|---|---|
| PubChem CID | 171307509 |
| Molecular Formula | C16H28Cl2N2O2 |
| Molecular Weight | 351.32 g/mol |
| Exact Mass | 350.15 |
| IUPAC Name | 3-[(1R)-1-piperazin-1-ylhexyl]benzene-1,2-diol;dihydrochloride |
| SMILES | CCCCC[C@H](c1cccc(O)c1O)N1CCNCC1.Cl.Cl |
| InChI | InChI=1S/C16H26N2O2.2ClH/c1-2-3-4-7-14(18-11-9-17-10-12-18)13-6-5-8-15(19)16(13)20;;/h5-6,8,14,17,19-20H,2-4,7,9-12H2,1H3;2*1H/t14-;;/m1../s1 |
| InChIKey | UVXKJWSLUNNTTJ-FMOMHUKBSA-N |
| XLogP | 3.47 |
| TPSA | 55.73 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 351.32 |
| LogP ≤ 5 | 3.47 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'mannich_A(296)', 'substructure': 'N/A'}, {'alert_name': 'catechol_A(92)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171307509 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.